Cervical Cancer Lawyers in New York

If Your Cervical Cancer Was Diagnosed Late

• What typically goes wrong (screening/follow-up): Cervical cancer is usually preventable or curable when regular Pap and HPV screening is done and abnormal results receive timely colposcopy, biopsy, and treatment. Delays often happen when recommended screening is not performed at the proper interval, abnormal Pap/HPV results are not acted on, follow-up tests are not ordered or scheduled, or patients are not informed about results or the need for further evaluation.
• What to collect: Pap test and HPV test reports, colposcopy and biopsy reports, office visit notes from gynecologists and primary-care providers, referral records, pathology reports, treatment records, portal messages or letters about abnormal results, and any reminder or follow-up notices (or proof they were not sent).
• Next step: Talk with a lawyer who can have your records reviewed by experts to see whether missed or delayed screening, misinterpretation of results, or failure to follow up allowed a precancerous lesion to progress to invasive cervical cancer in violation of accepted medical standards.

Doctors have at their disposal state-of-the-art tools to identify and diagnose cervical cancer at an early stage. But too often, they either fail to order the appropriate tests, order a test but don’t read the results, or fail to interpret test results correctly. This sort of medical malpractice can have devastating effects. Instead of being diagnosed early, when treatment can work, cancerous tumors are allowed to grow and spread for months, or even years.

The lawyers at the Porter Law Group have secured millions of dollars* for victims whose cancer diagnosis was delayed. We can recover compensation for you if your doctors:

• Failed to order a timely Pap screen.
• Failed to order a human papillomavirus (HPV) test.
• Failed to properly read or interpret your Pap or HPV test results.
• Failed to properly learn and respond to your pertinent family history.
• Failed to order appropriate follow-up tests.

Think you’re alone? You’re not. To learn more about the stories of people we’ve represented in lawsuits because their doctors failed to diagnose their cancer in a timely manner, click here.

Your doctors owe it to you to order the appropriate tests, and to properly interpret the results. If you’ve been denied available treatments, or you’re now facing a decreased survival rate because of your doctors’ failure to diagnose your cancer, contact us for a free case evaluation. Our lawyers and team of board-certified medical experts are here to give you the answers you and your family deserve.

*Prior results do not guarantee a similar outcome.

How Cervical Cancer Screening and Follow-Up Can Fail

Screening guidelines exist precisely because most cervical cancers develop slowly through detectable precancerous stages, and failures usually involve breakdowns in either screening or follow-up.

• Missed or delayed screening: Patients are not offered Pap/HPV screening beginning at age 21, or intervals extend well beyond recommended timing (for example, no Pap for more than 3 years, or no HPV-based test for more than 5 years in women who should be screened).
• Not offering age-appropriate test options: Patients aged 30-65 are not given one of the guideline-supported options (primary high-risk HPV testing, HPV/Pap cotesting every 5 years, or Pap alone every 3 years), increasing the risk that high-risk HPV infections or precancerous lesions remain undetected.
• Failure to act on abnormal results: Abnormal Pap or HPV results (for example, HPV-positive, ASC-US, LSIL, HSIL, or more serious cytology) are not followed by timely colposcopy, biopsy, or appropriate short-interval repeat testing as recommended by risk-based guidelines.
• Breakdowns in communicating results: Providers post abnormal test results in an electronic portal or chart but do not directly communicate the significance or next steps, and no reliable system ensures that patients with high-risk findings receive and complete recommended follow-up.
• Loss to follow-up after abnormal tests or treatment: Patients treated for high-grade precancer are not kept under extended surveillance (now recommended for at least 25 years), which can allow recurrent or persistent precancer to progress to invasive cancer.

How Cervical Cancer Screening Failures Happen

1. Pap and HPV Screening Failures

• Not screening at all or starting too late: Guidance for average-risk individuals with a cervix recommends starting screening at age 21, with cytology every 3 years from 21-29 and HPV-based options from 30-65, so a complete lack of screening during these years can allow precancer to progress silently.
• Inadequate screening intervals: For ages 30-65, recommended options include primary high-risk HPV testing every 5 years, HPV/Pap cotesting every 5 years, or Pap alone every 3 years. Extended gaps beyond these intervals increase the chance of missing high-risk HPV infections and high-grade lesions.
• Not offering HPV-based testing when appropriate: High-risk HPV testing is more sensitive than cytology alone for detecting CIN3+ lesions, and guidelines increasingly emphasize HPV-based approaches. Failing to adopt appropriate testing strategies in eligible patients may be considered a departure from evolving standards.

2. Follow-Up Breakdowns After Abnormal Results

• Failure to refer for colposcopy/biopsy: Risk-based management guidelines call for colposcopy or expedited excisional treatment (such as LEEP) in patients whose combination of current results, history, and HPV status puts their risk of CIN3+ above defined thresholds. Not providing this follow-up can allow high-grade precancer to go untreated.
• Delay in scheduling or performing recommended procedures: Even when colposcopy or biopsy is ordered, significant delays in scheduling or performing the procedure after a high-risk result can lead to progression from precancer to invasive cancer.
• No tracking of abnormal results: Systems that do not flag high-risk results or ensure that patients with abnormal Pap/HPV tests return for recommended follow-up contribute to preventable invasive cervical cancers.
• Insufficient long-term surveillance after treatment: Updated guidance recommends prolonged surveillance (at least 25 years) after treatment for high-grade precancer with HPV testing or cotesting at defined intervals, but failure to maintain this follow-up can miss recurrence or new precancerous lesions.

Do I Have a Cervical Cancer Delayed Diagnosis Case?

A delayed-diagnosis cervical cancer case usually turns on whether accepted screening and follow-up standards were not followed and whether that failure allowed a treatable precancer or early cancer to progress.

“Do I Have a Case?” Short Checklist

You may have a potential claim if:

• You were in the age range where cervical screening is recommended (generally 21-65) but did not receive Pap/HPV screening for many years.
• You had abnormal Pap or HPV results (for example, HPV-positive, ASC-US with HPV positivity, LSIL, HSIL, or more severe cytology), but no one arranged timely colposcopy, biopsy, or short-interval repeat testing.
• You were told prior results were “normal,” and later review of the slides or reports showed misread cytology or missed high-grade lesions.
• You underwent treatment for high-grade precancer but were not kept on recommended long-term surveillance and later developed invasive cervical cancer.
• Because of the delay, your cancer was diagnosed at a higher stage than it likely would have been, leading to more extensive treatment (such as radical surgery, chemoradiation) and a worse prognosis.

New York’s cancer-misdiagnosis timing rules (Lavern’s Law) also affect whether a lawsuit is still timely, so records and dates are critical.

Frequently Asked Questions

Can I Sue for Misdiagnosed or Late-Diagnosed Cervical Cancer?

In New York, a patient can bring a medical malpractice claim for misdiagnosed or late-diagnosed cervical cancer if they can show that a health-care provider departed from accepted medical practice (often by failing to follow evidence-based screening and risk-based follow-up guidelines) and that this failure allowed a precancer or early cancer to progress and cause additional harm.

These cases often involve missed or delayed Pap/HPV screening, failure to follow up abnormal results with colposcopy or biopsy, misinterpretation of cytology or pathology, or breakdowns in communicating and tracking high-risk findings.

New York’s statute of limitations for negligent failure to diagnose cancer or a malignant tumor (CPLR 214-a, as amended by Lavern’s Law) generally gives patients two and a half years from when they knew or reasonably should have known of the malpractice-related injury, subject to an outside limit from the date of the negligent act.

What Compensation Can I Recover for Cervical Cancer Misdiagnosis?

Compensation in a New York cervical cancer misdiagnosis case can include:

• Medical expenses for surgery, chemotherapy, radiation, fertility-preserving or reconstructive procedures, and ongoing surveillance.
• Lost income and loss of future earning capacity when treatment and long-term effects interfere with work.
• Non-economic damages, including pain and suffering and loss of enjoyment of life, which can be substantial for patients facing more aggressive treatment, chronic complications, or reduced life expectancy due to late diagnosis.

Where misdiagnosis leads to death, surviving family members may pursue a wrongful-death claim under New York law seeking funeral expenses and pecuniary losses.

What Is the 2-Week Rule for Cervical Cancer?

In the UK, “2-week wait” rules refer to targets for specialist assessment after an urgent suspected-cancer referral, but in cervical cancer practice more broadly, clinicians also use short “safety-net” timeframes to ensure prompt evaluation of suspicious symptoms or high-risk findings.

While there is no specific New York statute creating a “2-week rule” for cervical cancer, risk-based management guidance emphasizes timely colposcopy and biopsy when the estimated immediate risk of CIN3+ is high (for example, HPV-16-positive HSIL cytology), and significant delay in acting on such results can be inconsistent with accepted care.

Even without a formal statutory “2-week” requirement, unreasonable delays between high-risk results and diagnostic procedures are a common focus in malpractice evaluation.

What Is the 90-70-90 Rule for Cervical Cancer?

The 90-70-90 targets are global cervical cancer elimination goals endorsed by the World Health Organization and partner organizations: vaccinating 90% of girls fully against HPV by age 15, screening 70% of women at least twice with a high-performance test by ages 35 and 45, and treating 90% of women with precancerous lesions or invasive cervical cancer.

These benchmarks highlight the expectation that high-coverage HPV vaccination, regular screening, and effective treatment of detected disease can drive cervical cancer incidence and mortality toward elimination, and they underscore why failures in screening and follow-up are medically (and potentially legally) significant.

Is It Hard to Sue for HPV?

HPV infection itself is extremely common, and most infections clear without causing cancer. Screening guidelines are built around the reality that many adults will acquire high-risk HPV at some point.

Legal claims usually focus not on the mere presence of HPV, but on failures to prevent, detect, or manage HPV-related disease (such as not following cervical screening guidelines, not acting on abnormal HPV or Pap results, or not treating high-grade precancer that later progresses to invasive cancer).

Because causation and standard-of-care questions can be complex, HPV-related malpractice claims typically require expert review of whether a provider’s handling of screening, follow-up, or counseling fell below accepted practice and whether that lapse more likely than not led to the development or progression of cervical cancer.

Our Past Results Speak for Themselves

Our experienced trial lawyers have secured millions of dollars for patients whose cancer was misdiagnosed in the State of New York. Get in touch with us for a free consultation. We can get you and your family the answers you deserve.

Contact us at 833-PORTER9, or e-mail us at info@porterlawteam.com to discuss the details of our experience representing other clients and the results we were able to obtain in the past for clients who also suffered from cancer. In many ways, our results speak for themselves, and we will stand ready to help you and your family in your time of greatest need.